Stock MRK MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Share ownership Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2025-01-10 pm EST 		Pre-market 08:26:04 am
99.25 USD -0.60% Intraday chart for Merck & Co., Inc. 99.24 -0.01%
Jan. 10 Atropos Health, Inc. Collaborates with Merck for Rapid Evidence Generation to Accelerate Innovation for Life-Saving Treatments CI
Jan. 09 IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma MT

Share class: Merck & Co., Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A13,574,709,0222,528,032,964 ( 70.72 %) 1,045,073,377 ( 29.24 %) 70.72 %

Major shareholders: Merck & Co., Inc.

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.875 %
249,803,915 9.875 % 24 850 M $
BlackRock Advisors LLC
6.312 %
159,673,461 6.312 % 15 884 M $
State Street Corp.
4.705 %
119,026,412 4.705 % 11 841 M $
Wellington Trust Co., NA
2.997 %
75,809,383 2.997 % 7 542 M $
Geode Capital Management LLC
2.338 %
59,155,004 2.338 % 5 885 M $
Fidelity Management & Research Co. LLC
1.963 %
49,645,305 1.963 % 4 939 M $
BlackRock Life Ltd.
1.806 %
45,687,821 1.806 % 4 545 M $
Eaton Vance Management
1.755 %
44,391,822 1.755 % 4 416 M $
Merrill Lynch International
1.537 %
38,868,024 1.537 % 3 867 M $
Norges Bank (13F)
1.336 %
33,806,976 1.336 % 3 363 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
NameEquities%Valuation
Caixa DTVM SA
0.001383 %
279,910 0.001383 % 3 M $
Safra Asset Management Ltda.
0.000232 %
47,000 0.000232 % 574 549 $
BRAM - Bradesco Asset Management SA DTVM
0.000219 %
44,252 0.000219 % 540 956 $
XP Allocation Asset Management Ltda.
0.000068 %
13,687 0.000068 % 167 316 $
Banco J. Safra SA
0.000022 %
4,400 0.000022 % 53 788 $

Breakdown by shareholder type

Institutional58.95%
Other11.94%
State Street Corp.4.71%
Swedbank AB0.30%
Schweizerische Nationalbank0.30%
Sumitomo Mitsui Trust Group, Inc.0.26%
Manulife Financial Corp.0.20%
Governments0.13%
Skandinaviska Enskilda Banken AB0.09%
SEI Investments Co.0.08%
Regions Financial Corp.0.06%
The Bank of Nova Scotia0.05%
Rathbones Group Plc0.05%
ING Groep NV0.04%
Fifth Third Bancorp0.03%
First Financial Bankshares, Inc.0.03%
Peapack-Gladstone Financial Corp.0.03%
Individuals0.03%
Zurich Insurance Group AG0.02%
Old Republic International Corp.0.02%
Banco Bilbao Vizcaya Argentaria SA0.02%
Corebridge Financial, Inc.0.02%
Fairfax Financial Holdings Ltd.0.01%
Associated Banc-Corp0.01%
Atlantic Union Bankshares Corp.0.01%
Phoenix Financial Ltd.0.01%
W.R. Berkley Corp.0.01%
Pinnacle Financial Partners, Inc.0.01%
Silvercrest Asset Management Group, Inc.0.01%
Cullen/Frost Bankers, Inc.0.01%
Commerzbank AG0.01%
Unknown22.55%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 57.92%
United Kingdom 7.91%
Canada 2.71%
Norway 1.47%
France 1.22%
Sweden 1.00%
Australia 0.80%
Switzerland 0.72%
Japan 0.65%
Germany 0.50%
Denmark 0.46%
Netherlands 0.37%
Hong Kong 0.32%
South Korea 0.27%
Luxembourg 0.23%
Belgium 0.22%
Ireland 0.17%
Italy 0.12%
Finland 0.09%
Spain 0.07%
Austria 0.06%
Singapore 0.04%
Individuals 0.03%
Czech Republic 0.02%
New Zealand 0.02%
Israel 0.01%
Slovenia 0.01%
United Arab Emirates 0.01%
China 0.01%
South Africa 0.01%

Based on 1000 largest holdings

Company Profile

Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (67%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (22.1%); - sale of animal health products (9.4%); - other (1.5%). Net sales are distributed geographically as follows: the United States (47.4%), Europe/Middle East/Africa (22%), China (11.3%), Japan (5.3%), Asia/Pacific (5.4%), Latin America (5.1%) and other (3.5%).
Employees
71,000
Sector
Pharmaceuticals
Calendar
2025-01-13 - JP Morgan Healthcare Conference
More about the company
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Company Merck & Co., Inc.
  5. Share ownership